BRCA1 Tumor Suppressor Network: Focusing on Its Tail

Overview

Journal Cell Biosci

Publisher Biomed Central

Specialty Biology

Date 2012 Feb 29

PMID 22369660

Citations 45

Authors

Bin Wang

Affiliations

Soon will be listed here.

Abstract

Germline mutations of the BRCA1 tumor suppressor gene are a major cause of familial breast and ovarian cancer. BRCA1 plays critical roles in the DNA damage response that regulates activities of multiple repair and checkpoint pathways for maintaining genome stability. The BRCT domains of BRCA1 constitute a phospho-peptide binding domain recognizing a phospho-SPxF motif (S, serine; P, proline; × varies; F, phenylalanine). The BRCT domains are frequently targeted by clinically important mutations and most of these mutations disrupt the binding surface of the BRCT domains to phosphorylated peptides. The BRCT domain and its capability to bind phosphorylated protein is required for the tumor suppressor function of BRCA1. Through its BRCT phospho-binding ability BRCA1 forms at least three mutually exclusive complexes by binding to phosphorylated proteins Abraxas, Bach1 and CTIP. The A, B and C complexes, at lease partially undertake BRCA1's role in mechanisms of cell cycle checkpoint and DNA repair that maintain genome stability, thus may play important roles in BRCA1's tumor suppressor function.

Citing Articles

Phospho-Proteomics Analysis of Early Response to X-Ray Irradiation Reveals Molecular Mechanism Potentially Related to U251 Cell Radioresistance.

Ben Diouf O, Gilbert A, Bernay B, Syljuasen R, Tudor M, Temelie M Proteomes. 2025; 13(1.

PMID: 39846632 PMC: 11755531. DOI: 10.3390/proteomes13010001.

DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1.

Leung J, Miller K Trends Pharmacol Sci. 2024; 45(11):955-957.

PMID: 39389815 PMC: 11580024. DOI: 10.1016/j.tips.2024.09.008.

Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection.

Ceppi I, Dello Stritto M, Mutze M, Braunshier S, Mengoli V, Reginato G Nature. 2024; 634(8033):492-500.

PMID: 39261728 PMC: 11464378. DOI: 10.1038/s41586-024-07909-9.

DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair.

Tang H, Lu Y, Zeng R, Liu C, Shu Y, Wu Y Proc Natl Acad Sci U S A. 2024; 121(35):e2320804121.

PMID: 39172790 PMC: 11363320. DOI: 10.1073/pnas.2320804121.

Systematic investigation of BRCA1-A, -B, and -C complexes and their functions in DNA damage response and DNA repair.

Li S, Tang M, Xiong Y, Feng X, Wang C, Nie L Oncogene. 2024; 43(35):2621-2634.

PMID: 39068216 DOI: 10.1038/s41388-024-03108-y.

References

Wu-Baer F, Lagrazon K, Yuan W, Baer R . The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J Biol Chem. 2003; 278(37):34743-6. DOI: 10.1074/jbc.C300249200. View

Huertas P, Jackson S . Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem. 2009; 284(14):9558-65. PMC: 2666608. DOI: 10.1074/jbc.M808906200. View

Stewart G, Panier S, Townsend K, Al-Hakim A, Kolas N, Miller E . The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell. 2009; 136(3):420-34. DOI: 10.1016/j.cell.2008.12.042. View

Sun L, Chen Z . The novel functions of ubiquitination in signaling. Curr Opin Cell Biol. 2004; 16(2):119-26. DOI: 10.1016/j.ceb.2004.02.005. View

Thorslund T, West S . BRCA2: a universal recombinase regulator. Oncogene. 2007; 26(56):7720-30. DOI: 10.1038/sj.onc.1210870. View

Moldovan G, DAndrea A . How the fanconi anemia pathway guards the genome. Annu Rev Genet. 2009; 43:223-49. PMC: 2830711. DOI: 10.1146/annurev-genet-102108-134222. View

Yu X, Chini C, He M, Mer G, Chen J . The BRCT domain is a phospho-protein binding domain. Science. 2003; 302(5645):639-42. DOI: 10.1126/science.1088753. View

Antoniou A, Wang X, Fredericksen Z, McGuffog L, Tarrell R, Sinilnikova O . A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010; 42(10):885-92. PMC: 3130795. DOI: 10.1038/ng.669. View

Gupta R, Sharma S, Sommers J, Jin Z, Cantor S, Brosh Jr R . Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J Biol Chem. 2005; 280(27):25450-60. DOI: 10.1074/jbc.M501995200. View

10.

Song L, Rape M . Reverse the curse--the role of deubiquitination in cell cycle control. Curr Opin Cell Biol. 2008; 20(2):156-63. PMC: 2387050. DOI: 10.1016/j.ceb.2008.01.012. View

11.

Feng L, Huang J, Chen J . MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev. 2009; 23(6):719-28. PMC: 2661609. DOI: 10.1101/gad.1770609. View

12.

Christensen D, Brzovic P, Klevit R . E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol. 2007; 14(10):941-8. DOI: 10.1038/nsmb1295. View

13.

Wang B, Matsuoka S, Ballif B, Zhang D, Smogorzewska A, Gygi S . Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science. 2007; 316(5828):1194-8. PMC: 3573690. DOI: 10.1126/science.1139476. View

14.

Coleman K, Greenberg R . The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem. 2011; 286(15):13669-80. PMC: 3075711. DOI: 10.1074/jbc.M110.213728. View

15.

Cantor S, Guillemette S . Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 2011; 7(2):253-61. PMC: 3109611. DOI: 10.2217/fon.10.191. View

16.

Morris J, Pangon L, Boutell C, Katagiri T, Keep N, Solomon E . Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum Mol Genet. 2006; 15(4):599-606. DOI: 10.1093/hmg/ddi476. View

17.

Qvist P, Huertas P, Jimeno S, Nyegaard M, Hassan M, Jackson S . CtIP Mutations Cause Seckel and Jawad Syndromes. PLoS Genet. 2011; 7(10):e1002310. PMC: 3188555. DOI: 10.1371/journal.pgen.1002310. View

18.

Glickman M, Rubin D, Coux O, Wefes I, Pfeifer G, Cjeka Z . A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell. 1998; 94(5):615-23. DOI: 10.1016/s0092-8674(00)81603-7. View

19.

Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N . Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell. 2006; 22(6):719-729. DOI: 10.1016/j.molcel.2006.05.022. View

20.

Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A . Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 2011; 30(6):1079-92. PMC: 3061033. DOI: 10.1038/emboj.2011.27. View